{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T18:16:42Z","timestamp":1795025802428,"version":"4.10.2"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T00:00:00Z","timestamp":1726272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T00:00:00Z","timestamp":1726272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"DOI":"10.1186\/s40478-024-01859-z","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T08:02:28Z","timestamp":1726732948000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Evaluation of Rho kinase inhibitor effects on neuroprotection and neuroinflammation in an ex-vivo retinal explant model"],"prefix":"10.1186","volume":"12","author":[{"given":"\u00c9lodie","family":"Reboussin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Bastelica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilyes","family":"Benmessabih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Cordovilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Delarasse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabelle","family":"R\u00e9aux-Le Goazigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Brignole-Baudouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Olmi\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Baudouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Buffault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2029-9591","authenticated-orcid":false,"given":"St\u00e9phane","family":"M\u00e9lik Parsadaniantz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,14]]},"reference":[{"issue":"10414","key":"1859_CR1","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1016\/S0140-6736(23)01289-8","volume":"402","author":"H Jayaram","year":"2023","unstructured":"Jayaram H, Kolko M, Friedman DS, Gazzard G (2023) Glaucoma: now and beyond. Lancet 402(10414):1788\u20131801","journal-title":"Lancet"},{"issue":"18","key":"1859_CR2","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1001\/jama.2014.3192","volume":"311","author":"RN Weinreb","year":"2014","unstructured":"Weinreb RN, Aung T, Medeiros FA (2014) The pathophysiology and treatment of glaucoma: a review. JAMA 311(18):1901\u20131911","journal-title":"JAMA"},{"issue":"6","key":"1859_CR3","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.4103\/ijo.IJO_2239_21","volume":"70","author":"N Mohan","year":"2022","unstructured":"Mohan N, Chakrabarti A, Nazm N, Mehta R, Edward DP (2022) Newer advances in medical management of glaucoma. Indian J Ophthalmol 70(6):1920\u20131930","journal-title":"Indian J Ophthalmol"},{"issue":"8","key":"1859_CR4","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.3390\/ph16081172","volume":"16","author":"ML Salvetat","year":"2023","unstructured":"Salvetat ML, Pellegrini F, Spadea L, Salati C, Zeppieri M (2023) Pharmaceutical approaches to normal tension glaucoma. Pharmaceuticals (Basel) 16(8):1172","journal-title":"Pharmaceuticals (Basel)"},{"key":"1859_CR5","doi-asserted-by":"publisher","first-page":"100916","DOI":"10.1016\/j.preteyeres.2020.100916","volume":"83","author":"C Baudouin","year":"2021","unstructured":"Baudouin C, Kolko M, Melik-Parsadaniantz S, Messmer EM (2021) Inflammation in glaucoma: from the back to the front of the eye, and beyond. Prog Retin Eye Res 83:100916","journal-title":"Prog Retin Eye Res"},{"issue":"3","key":"1859_CR6","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3390\/cells9030535","volume":"9","author":"S M\u00e9lik Parsadaniantz","year":"2020","unstructured":"M\u00e9lik Parsadaniantz S, R\u00e9aux-le Goazigo A, Sapienza A, Habas C, Baudouin C (2020) Glaucoma: a degenerative optic neuropathy related to neuroinflammation? Cells 9(3):535","journal-title":"Cells"},{"key":"1859_CR7","doi-asserted-by":"publisher","first-page":"699623","DOI":"10.3389\/fphar.2021.699623","volume":"12","author":"AH Jassim","year":"2021","unstructured":"Jassim AH, Inman DM, Mitchell CH (2021) Crosstalk between dysfunctional mitochondria and inflammation in glaucomatous neurodegeneration. Front Pharmacol 12:699623","journal-title":"Front Pharmacol"},{"key":"1859_CR8","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12974-016-0509-7","volume":"13","author":"A Sapienza","year":"2016","unstructured":"Sapienza A, Raveu AL, Reboussin E, Roubeix C, Boucher C, D\u00e9gardin J et al (2016) Bilateral neuroinflammatory processes in visual pathways induced by unilateral ocular hypertension in the rat. J Neuroinflamm 13:44","journal-title":"J Neuroinflamm"},{"issue":"3","key":"1859_CR9","doi-asserted-by":"publisher","first-page":"391","DOI":"10.4103\/1673-5374.245465","volume":"14","author":"A Adornetto","year":"2019","unstructured":"Adornetto A, Russo R, Parisi V (2019) Neuroinflammation as a target for glaucoma therapy. Neural Regen Res mars 14(3):391\u2013394","journal-title":"Neural Regen Res mars"},{"issue":"1","key":"1859_CR10","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/jnr.24256","volume":"97","author":"X Wei","year":"2019","unstructured":"Wei X, Cho KS, Thee EF, Jager MJ, Chen DF (2019) Neuroinflammation and microglia in glaucoma: time for a paradigm shift. J Neurosci Res 97(1):70\u201376","journal-title":"J Neurosci Res"},{"issue":"5","key":"1859_CR11","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.survophthal.2021.02.003","volume":"66","author":"L Quaranta","year":"2021","unstructured":"Quaranta L, Bruttini C, Micheletti E, Konstas AGP, Michelessi M, Oddone F et al (2021) Glaucoma and neuroinflammation: an overview. Surv Ophthalmol 66(5):693\u2013713","journal-title":"Surv Ophthalmol"},{"key":"1859_CR12","doi-asserted-by":"publisher","first-page":"100998","DOI":"10.1016\/j.preteyeres.2021.100998","volume":"87","author":"G Tezel","year":"2022","unstructured":"Tezel G (2022) Molecular regulation of neuroinflammation in glaucoma: current knowledge and the ongoing search for new treatment targets. Prog Retin Eye Res 87:100998","journal-title":"Prog Retin Eye Res"},{"key":"1859_CR13","doi-asserted-by":"publisher","first-page":"214","DOI":"10.3389\/fnagi.2017.00214","volume":"9","author":"AI Ramirez","year":"2017","unstructured":"Ramirez AI, de Hoz R, Salobrar-Garcia E, Salazar JJ, Rojas B, Ajoy D et al (2017) The role of microglia in retinal neurodegeneration: Alzheimer\u2019s disease, parkinson, and glaucoma. Front Aging Neurosci 9:214","journal-title":"Front Aging Neurosci"},{"key":"1859_CR14","doi-asserted-by":"publisher","first-page":"101169","DOI":"10.1016\/j.preteyeres.2023.101169","volume":"93","author":"Y Miao","year":"2023","unstructured":"Miao Y, Zhao GL, Cheng S, Wang Z, Yang XL (2023) Activation of retinal glial cells contributes to the degeneration of ganglion cells in experimental glaucoma. Prog Retin Eye Res 93:101169","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"1859_CR15","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s12035-014-9070-5","volume":"53","author":"Y Tang","year":"2016","unstructured":"Tang Y, Le W (2016) Differential roles of M1 and M2 microglia in neurodegenerative diseases. Mol Neurobiol 53(2):1181\u20131194","journal-title":"Mol Neurobiol"},{"issue":"21","key":"1859_CR16","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.1016\/j.neuron.2022.10.020","volume":"110","author":"RC Paolicelli","year":"2022","unstructured":"Paolicelli RC, Sierra A, Stevens B, Tremblay ME, Aguzzi A, Ajami B et al (2022) Microglia states and nomenclature: a field at its crossroads. Neuron 110(21):3458\u20133483","journal-title":"Neuron"},{"key":"1859_CR17","doi-asserted-by":"publisher","first-page":"843558","DOI":"10.3389\/fimmu.2022.843558","volume":"13","author":"SK Wang","year":"2022","unstructured":"Wang SK, Cepko CL (2022) Targeting microglia to treat degenerative eye diseases. Front Immunol 13:843558","journal-title":"Front Immunol"},{"issue":"5","key":"1859_CR18","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1097\/IJG.0000000000000200","volume":"25","author":"JW Wang","year":"2016","unstructured":"Wang JW, Chen SD, Zhang XL, Jonas JB (2016) Retinal microglia in glaucoma. J Glaucoma 25(5):459\u2013465","journal-title":"J Glaucoma"},{"issue":"10","key":"1859_CR19","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1080\/13543776.2019.1670812","volume":"29","author":"E Berrino","year":"2019","unstructured":"Berrino E, Supuran CT (2019) Rho-kinase inhibitors in the management of glaucoma. Expert Opin Ther Pat 29(10):817\u2013827","journal-title":"Expert Opin Ther Pat"},{"issue":"1","key":"1859_CR20","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s10792-021-02002-w","volume":"42","author":"BC Saha","year":"2022","unstructured":"Saha BC, Kumari R, Kushumesh R, Ambasta A, Sinha BP (2022) Status of Rho kinase inhibitors in glaucoma therapeutics-an overview. Int Ophthalmol 42(1):281\u2013294","journal-title":"Int Ophthalmol"},{"key":"1859_CR21","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2147\/JEP.S259297","volume":"13","author":"G Al-Humimat","year":"2021","unstructured":"Al-Humimat G, Marashdeh I, Daradkeh D, Kooner K (2021) Investigational Rho kinase inhibitors for the treatment of glaucoma. J Exp Pharmacol 13:197\u2013212","journal-title":"J Exp Pharmacol"},{"issue":"10","key":"1859_CR22","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1007\/s40265-019-01130-z","volume":"79","author":"EM Schehlein","year":"2019","unstructured":"Schehlein EM, Robin AL (2019) Rho-associated kinase inhibitors: evolving strategies in glaucoma treatment. Drugs 79(10):1031\u20131036","journal-title":"Drugs"},{"key":"1859_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2018.03.008","volume":"189","author":"JC Koch","year":"2018","unstructured":"Koch JC, Tatenhorst L, Roser AE, Saal KA, T\u00f6nges L, Lingor P (2018) ROCK inhibition in models of neurodegeneration and its potential for clinical translation. Pharmacol Ther 189:1\u201321","journal-title":"Pharmacol Ther"},{"issue":"4","key":"1859_CR24","doi-asserted-by":"publisher","first-page":"455","DOI":"10.2174\/1389450117666160401123825","volume":"18","author":"CM Chong","year":"2017","unstructured":"Chong CM, Ai N, Lee SMY (2017) ROCK in CNS: different roles of isoforms and therapeutic target for neurodegenerative disorders. Curr Drug Targets 18(4):455\u2013462","journal-title":"Curr Drug Targets"},{"issue":"1","key":"1859_CR25","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13195-017-0320-4","volume":"9","author":"BJ Aguilar","year":"2017","unstructured":"Aguilar BJ, Zhu Y, Lu Q (2017) Rho GTPases as therapeutic targets in Alzheimer\u2019s disease. Alzheimers Res Ther 9(1):97","journal-title":"Alzheimers Res Ther"},{"key":"1859_CR26","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.pneurobio.2015.06.002","volume":"131","author":"S Van de Velde","year":"2015","unstructured":"Van de Velde S, De Groef L, Stalmans I, Moons L, Van Hove I (2015) Towards axonal regeneration and neuroprotection in glaucoma: Rho kinase inhibitors as promising therapeutics. Prog Neurobiol 131:105\u2013119","journal-title":"Prog Neurobiol"},{"issue":"24","key":"1859_CR27","doi-asserted-by":"publisher","first-page":"3659","DOI":"10.1002\/elps.201200470","volume":"33","author":"M Raad","year":"2012","unstructured":"Raad M, El Tal T, Gul R, Mondello S, Zhang Z, Boustany RM et al (2012) Neuroproteomics approach and neurosystems biology analysis: ROCK inhibitors as promising therapeutic targets in neurodegeneration and neurotrauma. Electrophoresis 33(24):3659\u20133668","journal-title":"Electrophoresis"},{"issue":"1","key":"1859_CR28","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1159\/000350138","volume":"32","author":"A Alt","year":"2013","unstructured":"Alt A, Hilgers RD, Tura A, Nassar K, Schneider T, Hueber A et al (2013) The neuroprotective potential of Rho-kinase inhibition in promoting cell survival and reducing reactive gliosis in response to hypoxia in isolated bovine retina. Cell Physiol Biochem 32(1):218\u2013234","journal-title":"Cell Physiol Biochem"},{"issue":"1","key":"1859_CR29","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1167\/iovs.08-1973","volume":"50","author":"A Tura","year":"2009","unstructured":"Tura A, Schuettauf F, Monnier PP, Bartz-Schmidt KU, Henke-Fahle S (2009) Efficacy of Rho-kinase inhibition in promoting cell survival and reducing reactive gliosis in the rodent retina. Invest Ophthalmol Vis Sci 50(1):452\u2013461","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"1859_CR30","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1002\/glia.24442","volume":"71","author":"K Sato","year":"2023","unstructured":"Sato K, Ohno-Oishi M, Yoshida M, Sato T, Aizawa T, Sasaki Y et al (2023) The GPR84 molecule is a mediator of a subpopulation of retinal microglia that promote TNF\/IL-1\u03b1 expression via the rho-ROCK pathway after optic nerve injury. Glia 71(11):2609\u20132622","journal-title":"Glia"},{"issue":"3","key":"1859_CR31","doi-asserted-by":"publisher","first-page":"588","DOI":"10.3390\/cells10030588","volume":"10","author":"V Holan","year":"2021","unstructured":"Holan V, Palacka K, Hermankova B (2021) Mesenchymal stem cell-based therapy for retinal degenerative diseases: experimental models and clinical trials. Cells 10(3):588","journal-title":"Cells"},{"issue":"1","key":"1859_CR32","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12974-022-02418-w","volume":"19","author":"\u00c9 Reboussin","year":"2022","unstructured":"Reboussin \u00c9, Buffault J, Brignole-Baudouin F, R\u00e9aux-Le Goazigo A, Riancho L, Olmiere C et al (2022) Evaluation of neuroprotective and immunomodulatory properties of mesenchymal stem cells in an ex vivo retinal explant model. J Neuroinflamm 19(1):63","journal-title":"J Neuroinflamm"},{"key":"1859_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tice.2018.01.005","volume":"51","author":"Y Li","year":"2018","unstructured":"Li Y, Zhang Y, Qi S, Su G (2018) Retinal organotypic culture\u2014a candidate for research on retinas. Tissue Cell 51:1\u20137","journal-title":"Tissue Cell"},{"key":"1859_CR34","doi-asserted-by":"publisher","first-page":"100880","DOI":"10.1016\/j.preteyeres.2020.100880","volume":"81","author":"S Schnichels","year":"2021","unstructured":"Schnichels S, Paquet-Durand F, L\u00f6scher M, Tsai T, Hurst J, Joachim SC et al (2021) Retina in a dish: cell cultures, retinal explants and animal models for common diseases of the retina. Prog Retin Eye Res 81:100880","journal-title":"Prog Retin Eye Res"},{"issue":"3","key":"1859_CR35","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1159\/000497296","volume":"206","author":"CL Rettinger","year":"2018","unstructured":"Rettinger CL, Wang HC (2018) Current advancements in the development and characterization of full-thickness adult neuroretina organotypic culture systems. Cells Tissues Organs 206(3):119\u2013132","journal-title":"Cells Tissues Organs"},{"issue":"6","key":"1859_CR36","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1167\/iovs.18-25156","volume":"60","author":"V Alarautalahti","year":"2019","unstructured":"Alarautalahti V, Ragauskas S, Hakkarainen JJ, Uusitalo-J\u00e4rvinen H, Uusitalo H, Hyttinen J et al (2019) Viability of mouse retinal explant cultures assessed by preservation of functionality and morphology. Invest Ophthalmol Vis Sci 60(6):1914\u20131927","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"1859_CR37","doi-asserted-by":"publisher","first-page":"3309","DOI":"10.1167\/iovs.10-6873","volume":"52","author":"ND Bull","year":"2011","unstructured":"Bull ND, Johnson TV, Welsapar G, DeKorver NW, Tomarev SI, Martin KR (2011) Use of an adult rat retinal explant model for screening of potential retinal ganglion cell neuroprotective therapies. Invest Ophthalmol Vis Sci 52(6):3309\u20133320","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"14","key":"1859_CR38","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.2174\/0929867325666181031102829","volume":"27","author":"V Abbhi","year":"2020","unstructured":"Abbhi V, Piplani P (2020) Rho-kinase (ROCK) inhibitors\u2014a neuroprotective therapeutic paradigm with a focus on ocular utility. CMC 27(14):2222\u20132256","journal-title":"CMC"},{"issue":"4","key":"1859_CR39","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.3390\/jcm11041001","volume":"11","author":"J Buffault","year":"2022","unstructured":"Buffault J, Brignole-Baudouin F, Reboussin \u00c9, Kessal K, Labb\u00e9 A, M\u00e9lik Parsadaniantz S et al (2022) The dual effect of Rho-kinase inhibition on trabecular meshwork cells cytoskeleton and extracellular matrix in an in vitro model of glaucoma. J Clin Med 11(4):1001","journal-title":"J Clin Med"},{"key":"1859_CR40","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.exer.2016.08.023","volume":"158","author":"PV Rao","year":"2017","unstructured":"Rao PV, Pattabiraman PP, Kopczynski C (2017) Role of the Rho GTPase\/Rho kinase signaling pathway in pathogenesis and treatment of glaucoma: bench to bedside research. Exp Eye Res 158:23\u201332","journal-title":"Exp Eye Res"},{"issue":"8","key":"1859_CR41","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1097\/IJG.0b013e318241b83c","volume":"21","author":"B Goldhagen","year":"2012","unstructured":"Goldhagen B, Proia AD, Epstein DL, Rao PV (2012) Elevated levels of RhoA in the optic nerve head of human eyes with glaucoma. J Glaucoma 21(8):530\u2013538","journal-title":"J Glaucoma"},{"key":"1859_CR42","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.exer.2016.07.006","volume":"158","author":"PX Shaw","year":"2017","unstructured":"Shaw PX, Sang A, Wang Y, Ho D, Douglas C, Dia L et al (2017) Topical administration of a Rock\/Net inhibitor promotes retinal ganglion cell survival and axon regeneration after optic nerve injury. Exp Eye Res 158:33\u201342","journal-title":"Exp Eye Res"},{"issue":"2","key":"1859_CR43","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/ceo.13434","volume":"47","author":"A Murali","year":"2019","unstructured":"Murali A, Ramlogan-Steel CA, Andrzejewski S, Steel JC, Layton CJ (2019) Retinal explant culture: a platform to investigate human neuro-retina. Clin Exp Ophthalmol 47(2):274\u2013285","journal-title":"Clin Exp Ophthalmol"},{"issue":"4","key":"1859_CR44","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.survophthal.2012.08.010","volume":"58","author":"R Vohra","year":"2013","unstructured":"Vohra R, Tsai JC, Kolko M (2013) The role of inflammation in the pathogenesis of glaucoma. Surv Ophthalmol 58(4):311\u2013320","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"1859_CR45","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00417-007-0666-6","volume":"246","author":"A Hirata","year":"2008","unstructured":"Hirata A, Inatani M, Inomata Y, Yonemura N, Kawaji T, Honjo M et al (2008) Y-27632, a Rho-associated protein kinase inhibitor, attenuates neuronal cell death after transient retinal ischemia. Graefes Arch Clin Exp Ophthalmol 246(1):51\u201359","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"1859_CR46","first-page":"137","volume":"42","author":"M Honjo","year":"2001","unstructured":"Honjo M, Tanihara H, Inatani M, Kido N, Sawamura T, Yue BY et al (2001) Effects of rho-associated protein kinase inhibitor Y-27632 on intraocular pressure and outflow facility. Invest Ophthalmol Vis Sci 42(1):137\u2013144","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"1859_CR47","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1080\/02713680902783763","volume":"34","author":"M Nishio","year":"2009","unstructured":"Nishio M, Fukunaga T, Sugimoto M, Ikesugi K, Sumi K, Hidaka H et al (2009) The effect of the H-1152P, a potent Rho-associated coiled coil-formed protein kinase inhibitor, in rabbit normal and ocular hypertensive eyes. Curr Eye Res 34(4):282\u2013286","journal-title":"Curr Eye Res"},{"issue":"7","key":"1859_CR48","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.1167\/iovs.16-20974","volume":"58","author":"EH Zhou","year":"2017","unstructured":"Zhou EH, Paolucci M, Dryja TP, Manley T, Xiang C, Rice DS et al (2017) A compact whole-eye perfusion system to evaluate pharmacologic responses of outflow facility. Invest Ophthalmol Vis Sci 58(7):2991\u20133003","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"1859_CR49","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1159\/000353568","volume":"20","author":"C Gao","year":"2013","unstructured":"Gao C, Huang L, Long Y, Zheng J, Yang J, Pu S et al (2013) Y-39983, a selective Rho-kinase inhibitor, attenuates experimental autoimmune encephalomyelitis via inhibition of demyelination. NeuroImmunoModulation 20(6):334\u2013340","journal-title":"NeuroImmunoModulation"},{"issue":"2","key":"1859_CR50","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0014-5793(96)00811-3","volume":"392","author":"O Nakagawa","year":"1996","unstructured":"Nakagawa O, Fujisawa K, Ishizaki T, Saito Y, Nakao K, Narumiya S (1996) ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine\/threonine kinase in mice. FEBS Lett 392(2):189\u2013193","journal-title":"FEBS Lett"},{"issue":"3","key":"1859_CR51","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1001\/archophthalmol.2007.76","volume":"126","author":"H Tanihara","year":"2008","unstructured":"Tanihara H, Inatani M, Honjo M, Tokushige H, Azuma J, Araie M (2008) Intraocular pressure-lowering effects and safety of topical administration of a selective ROCK inhibitor, SNJ-1656, in healthy volunteers. Arch Ophthalmol 126(3):309\u2013315","journal-title":"Arch Ophthalmol"},{"issue":"7","key":"1859_CR52","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.1167\/iovs.05-1617","volume":"48","author":"H Tokushige","year":"2007","unstructured":"Tokushige H, Inatani M, Nemoto S, Sakaki H, Katayama K, Uehata M et al (2007) Effects of topical administration of y-39983, a selective rho-associated protein kinase inhibitor, on ocular tissues in rabbits and monkeys. Invest Ophthalmol Vis Sci 48(7):3216\u20133222","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"1859_CR53","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.expneurol.2007.02.002","volume":"205","author":"H Sagawa","year":"2007","unstructured":"Sagawa H, Terasaki H, Nakamura M, Ichikawa M, Yata T, Tokita Y et al (2007) A novel ROCK inhibitor, Y-39983, promotes regeneration of crushed axons of retinal ganglion cells into the optic nerve of adult cats. Exp Neurol 205(1):230\u2013240","journal-title":"Exp Neurol"},{"issue":"3","key":"1859_CR54","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.3892\/or.2012.2205","volume":"29","author":"Z Yang","year":"2013","unstructured":"Yang Z, Wang J, Liu X, Cheng Y, Deng L, Zhong Y (2013) Y-39983 downregulates RhoA\/Rho-associated kinase expression during its promotion of axonal regeneration. Oncol Rep 29(3):1140\u20131146","journal-title":"Oncol Rep"},{"issue":"10","key":"1859_CR55","doi-asserted-by":"publisher","first-page":"964","DOI":"10.3109\/02713683.2011.599106","volume":"36","author":"H Tokushige","year":"2011","unstructured":"Tokushige H, Waki M, Takayama Y, Tanihara H (2011) Effects of Y-39983, a selective Rho-associated protein kinase inhibitor, on blood flow in optic nerve head in rabbits and axonal regeneration of retinal ganglion cells in rats. Curr Eye Res 36(10):964\u2013970","journal-title":"Curr Eye Res"},{"issue":"Pt 1","key":"1859_CR56","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/brain\/awm284","volume":"131","author":"P Lingor","year":"2008","unstructured":"Lingor P, T\u00f6nges L, Pieper N, Bermel C, Barski E, Planchamp V et al (2008) ROCK inhibition and CNTF interact on intrinsic signalling pathways and differentially regulate survival and regeneration in retinal ganglion cells. Brain 131(Pt 1):250\u2013263","journal-title":"Brain"},{"issue":"4","key":"1859_CR57","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.mcn.2009.09.005","volume":"42","author":"C Bermel","year":"2009","unstructured":"Bermel C, T\u00f6nges L, Planchamp V, Gillardon F, Weishaupt JH, Dietz GPH et al (2009) Combined inhibition of Cdk5 and ROCK additively increase cell survival, but not the regenerative response in regenerating retinal ganglion cells. Mol Cell Neurosci 42(4):427\u2013437","journal-title":"Mol Cell Neurosci"},{"key":"1859_CR58","doi-asserted-by":"publisher","first-page":"875662","DOI":"10.3389\/fphar.2022.875662","volume":"13","author":"L Lambuk","year":"2022","unstructured":"Lambuk L, Mohd Lazaldin MA, Ahmad S, Iezhitsa I, Agarwal R, Uskokovi\u0107 V et al (2022) Brain-derived neurotrophic factor-mediated neuroprotection in glaucoma: a review of current state of the art. Front Pharmacol 13:875662","journal-title":"Front Pharmacol"},{"key":"1859_CR59","doi-asserted-by":"publisher","first-page":"212936","DOI":"10.1016\/j.bioadv.2022.212936","volume":"138","author":"S Lin","year":"2022","unstructured":"Lin S, Gao W, Zhu C, Lou Q, Ye C, Ren Y et al (2022) Efficiently suppress of ferroptosis using deferoxamine nanoparticles as a new method for retinal ganglion cell protection after traumatic optic neuropathy. Biomater Adv 138:212936","journal-title":"Biomater Adv"},{"issue":"1","key":"1859_CR60","doi-asserted-by":"publisher","first-page":"e0280548","DOI":"10.1371\/journal.pone.0280548","volume":"18","author":"Y Huang","year":"2023","unstructured":"Huang Y, Peng J, Liang Q (2023) Identification of key ferroptosis genes in diabetic retinopathy based on bioinformatics analysis. PLoS ONE 18(1):e0280548","journal-title":"PLoS ONE"},{"issue":"4","key":"1859_CR61","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/ncb1236","volume":"7","author":"Z Li","year":"2005","unstructured":"Li Z, Dong X, Wang Z, Liu W, Deng N, Ding Y et al (2005) Regulation of PTEN by Rho small GTPases. Nat Cell Biol 7(4):399\u2013404","journal-title":"Nat Cell Biol"},{"issue":"4","key":"1859_CR62","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nn1869","volume":"10","author":"MM Semenova","year":"2007","unstructured":"Semenova MM, M\u00e4ki-Hokkonen AMJ, Cao J, Komarovski V, Forsberg KM, Koistinaho M et al (2007) Rho mediates calcium-dependent activation of p38alpha and subsequent excitotoxic cell death. Nat Neurosci 10(4):436\u2013443","journal-title":"Nat Neurosci"},{"key":"1859_CR63","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/1742-2094-11-98","volume":"11","author":"JD Cherry","year":"2014","unstructured":"Cherry JD, Olschowka JA, O\u2019Banion MK (2014) Neuroinflammation and M2 microglia: the good, the bad, and the inflamed. J Neuroinflamm 11:98","journal-title":"J Neuroinflamm"},{"key":"1859_CR64","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3389\/fnana.2017.00077","volume":"11","author":"T Zhou","year":"2017","unstructured":"Zhou T, Huang Z, Sun X, Zhu X, Zhou L, Li M et al (2017) Microglia polarization with M1\/M2 phenotype changes in rd1 mouse model of retinal degeneration. Front Neuroanat 11:77","journal-title":"Front Neuroanat"},{"key":"1859_CR65","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3389\/fnagi.2017.00094","volume":"9","author":"AE Roser","year":"2017","unstructured":"Roser AE, T\u00f6nges L, Lingor P (2017) Modulation of microglial activity by Rho-kinase (ROCK) inhibition as therapeutic strategy in Parkinson\u2019s disease and amyotrophic lateral sclerosis. Front Aging Neurosci 9:94","journal-title":"Front Aging Neurosci"},{"issue":"6","key":"1859_CR66","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1016\/j.ymthe.2023.02.018","volume":"31","author":"H Ma","year":"2023","unstructured":"Ma H, Wang C, Liang S, Yu X, Yuan Y, Lv Z et al (2023) ROCK inhibition enhanced hepatocyte liver engraftment by retaining membrane CD59 and attenuating complement activation. Mol Ther 31(6):1846\u20131856","journal-title":"Mol Ther"},{"key":"1859_CR67","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/978-1-4419-5635-4_7","volume":"703","author":"L Ren","year":"2010","unstructured":"Ren L, Danias J (2010) A role for complement in glaucoma? Adv Exp Med Biol 703:95\u2013104","journal-title":"Adv Exp Med Biol"},{"issue":"8","key":"1859_CR68","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.3390\/biom11081239","volume":"11","author":"S Coyle","year":"2021","unstructured":"Coyle S, Khan MN, Chemaly M, Callaghan B, Doyle C, Willoughby CE et al (2021) Targeting the NLRP3 inflammasome in glaucoma. Biomolecules 11(8):1239","journal-title":"Biomolecules"},{"issue":"1","key":"1859_CR69","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00204-014-1238-2","volume":"89","author":"S Kanno","year":"2015","unstructured":"Kanno S, Hirano S, Chiba S, Takeshita H, Nagai T, Takada M et al (2015) The role of Rho-kinases in IL-1\u03b2 release through phagocytosis of fibrous particles in human monocytes. Arch Toxicol 89(1):73\u201385","journal-title":"Arch Toxicol"},{"issue":"1","key":"1859_CR70","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13024-020-00372-w","volume":"15","author":"H Chen","year":"2020","unstructured":"Chen H, Deng Y, Gan X, Li Y, Huang W, Lu L et al (2020) NLRP12 collaborates with NLRP3 and NLRC4 to promote pyroptosis inducing ganglion cell death of acute glaucoma. Mol Neurodegener 15(1):26","journal-title":"Mol Neurodegener"},{"issue":"11","key":"1859_CR71","doi-asserted-by":"publisher","first-page":"5697","DOI":"10.1167\/iovs.10-5407","volume":"51","author":"C Luo","year":"2010","unstructured":"Luo C, Yang X, Kain AD, Powell DW, Kuehn MH, Tezel G (2010) Glaucomatous tissue stress and the regulation of immune response through glial Toll-like receptor signaling. Invest Ophthalmol Vis Sci 51(11):5697\u20135707","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"1859_CR72","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.drudis.2019.03.029","volume":"24","author":"EL Fletcher","year":"2019","unstructured":"Fletcher EL, Wang AY, Jobling AI, Rutar MV, Greferath U, Gu B et al (2019) Targeting P2X7 receptors as a means for treating retinal disease. Drug Discov Today 24(8):1598\u20131605","journal-title":"Drug Discov Today"},{"key":"1859_CR73","doi-asserted-by":"publisher","first-page":"109332","DOI":"10.1016\/j.neuropharm.2022.109332","volume":"223","author":"PA D\u00e9chelle-Marquet","year":"2023","unstructured":"D\u00e9chelle-Marquet PA, Guillonneau X, Sennlaub F, Delarasse C (2023) P2X7-dependent immune pathways in retinal diseases. Neuropharmacology 223:109332","journal-title":"Neuropharmacology"},{"issue":"9","key":"1859_CR74","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.tips.2007.07.002","volume":"28","author":"F Di Virgilio","year":"2007","unstructured":"Di Virgilio F (2007) Liaisons dangereuses: P2X7 and the inflammasome. Trends Pharmacol Sci 28(9):465\u2013472","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"1859_CR75","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1167\/iovs.12-10968","volume":"54","author":"N Niyadurupola","year":"2013","unstructured":"Niyadurupola N, Sidaway P, Ma N, Rhodes JD, Broadway DC, Sanderson J (2013) P2X7 receptor activation mediates retinal ganglion cell death in a human retina model of ischemic neurodegeneration. Invest Ophthalmol Vis Sci 54(3):2163\u20132170","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"1859_CR76","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1002\/jnr.1104","volume":"64","author":"L Yuan","year":"2001","unstructured":"Yuan L, Neufeld AH (2001) Activated microglia in the human glaucomatous optic nerve head. J Neurosci Res 64(5):523\u2013532","journal-title":"J Neurosci Res"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-024-01859-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-024-01859-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-024-01859-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T08:07:05Z","timestamp":1726733225000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-024-01859-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,14]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1859"],"URL":"https:\/\/doi.org\/10.1186\/s40478-024-01859-z","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,14]]},"assertion":[{"value":"25 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments were conducted after evaluation and approval by the Institutional Animal Care and Use Committee in accordance with the guidelines of Directive 2010\/63\/EU of the European Parliament on the protection of animals used for scientific purposes.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"C\u00e9line Olmi\u00e8re: employee of the Laboratoires Th\u00e9a. Christophe Baudouin: Financial support and consultant (Alcon, Allergan; Santen, Laboratoires Th\u00e9a). No competing interest to declare for the other authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"150"}}